NCT00637611View on ClinicalTrials.gov

Single-Center, Double-Blind, Randomized , Parallel Study Comparing Onset of Action, Efficacy & Safety of a Single-Dose of Fexofenadine HCl 180 mg vs Montelukast Na 10 mg & Placebo in Treating Seasonal Allergic Rhinitis Subjects in an Allergen Exposure Unit

PHASE4CompletedINTERVENTIONAL
Enrollment

1,010

Participants

Timeline

Start Date

February 28, 2003

Study Completion Date

April 30, 2003

Conditions
Seasonal Allergic Rhinitis
Interventions
DRUG

Fexofenadine HCl

Trial Locations (1)

08807

Sanofi-Aventis, Bridgewater

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00637611 - Single-Center, Double-Blind, Randomized , Parallel Study Comparing Onset of Action, Efficacy & Safety of a Single-Dose of Fexofenadine HCl 180 mg vs Montelukast Na 10 mg & Placebo in Treating Seasonal Allergic Rhinitis Subjects in an Allergen Exposure Unit | Biotech Hunter | Biotech Hunter